Lewis & Roberts
RX-Attorneys.com

Fosamax Litigation



Click here to watch our Fosamax information video.

Fosamax may cause you to lose teeth, suffer from rotting jawbones and deteriorate your jaw to the extent that bone is exposed. Fosamax is manufactured by Merck & Company, the same company that manufactured and then pulled, Vioxx from the market.  Fosamax was approved by the Food & Drug Administration in 1995. It is commonly used to treat patients with osteoporosis.

Fosamax has been linked to a serious bone disease called Osteonecrosis of the jaw or "ONJ." ONJ may cause rotting and decay of the jaw bone leading to exposed bone and/or lost and rotting teeth.

Fosamax, and similar bone-strengthening drugs Aredia and Zometa, belong to a category known as bisphosphonates.  Pursuant to an FDA request, Merck revised its Fosamax information in July 2005 to include a reference to ONJ. The ONJ reference is, however, only found on page 13 of a 22 page document that is provided to pharmasicts.  We believe that Merck may have withheld and/or misinterpreted  Fosamax study information on the drug's link to ONJ.

Not surprisingly, Fosamax is Merck's second best selling drug behind Vioxx.  Fosamax sales were anticipated to be $3.3 to $3.6 billion in 2005.

Contact us to report any potential claims..  Someone will be in touch with you shortly to discuss your potential claim.